亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Minimally Invasive Assessment of Peripheral Residual Disease During Maintenance or Observation in Transplant-Eligible Patients With Multiple Myeloma

医学 多发性骨髓瘤 内科学 微小残留病 临床终点 肿瘤科 临床试验 骨髓 代理终结点 疾病 外科
作者
Marta Lasa,Laura Notarfranchi,Cristina Agulló,C. González,Sérgio Luís de Castro Júnior,José J. Pérez,Leire Burgos,Camilla Guerrero,Marı́a José Calasanz,Juan Flores‐Montero,Albert Oriol,Joan Bargay,Rafael Ríos,Valentín Cabañas,Carmen Cabrera,R. Martínez‐Martínez,Cristina Encinas,Felipe de Arriba,Miguel‐Teodoro Hernández,Luis Palomera,Alberto Órfão,Joaquín Martínez‐López,Maria-Victoria Mateos,Jesús F. San Miguel,Juan José Lahuerta,Laura Rosiñol,Joan Bladé,María‐Teresa Cedena,Noemí Puig,Bruno Paiva,María Casanova,Carmen Couto,Estrella Carrillo,Esther González,Ana Pilar González-Rodríguez,Antònia Sampol,Alexia Suárez,Carmen Montes,Ma del Carmen Calle,Luís Felipe Casado,Dunia de Miguel,Ángela Ibáñez,Jorge Labrador,Aránzazu García,Fernando Escalante,Carlos Iván Aguilar Gaibor,Lourdes Escoda,Ana María Sureda,Cristina Motlló,Yolanda González,Eugenia Abella Monreal,Juan A. Soler,Miquel Granell,Maria-Elena Cabezudo,Josep Ma Martí,Antonio García,Mercedes Gironella,Ana M. S. de Dios,José Ángel Méndez,Marta Sonia González,Ma José Nájera,Francisco Javier Peñalver,Pilar Bravo,José‐Ángel Hernández‐Rivas,Jaime Pérez de Oteyza,Rebeca Iglesias del Barrio,Ana López de la Guía,Adrián Alegre,Isabel Krsnik,Elena Ruíz,Ma Jesús Blanchard,Belén Íñigo,Eugenio Giménez,Rosalía Riaza,Elena Prieto,Marta Romera,Jose Ma Moraleda,Felipe Prósper,José-María Arguiñano,María Puente,Xabier Gutiérrez,Ana Isabel Teruel,Paz Rivas,Isidro Jarque,Ángel Martín Fernández,Amparo Santamaría,Carmen Martínez
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
标识
DOI:10.1200/jco.24.00635
摘要

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. In multiple myeloma (MM), measurable residual disease (MRD) is assessed in bone marrow (BM). However, less invasive evaluation of peripheral residual disease (PRD) in blood could be advantageous and less cumbersome. We investigated the prognostic value of PRD monitoring after 24 cycles of maintenance in 138 transplant-eligible patients with MM enrolled in the GEM2012MENOS65/GEM2014MAIN clinical trials. PRD was assessed using next-generation flow (NGF) and mass spectrometry (MS). Positive PRD by NGF in 16/138 (11.5%) patients was associated with a 13-fold increased risk of progression and/or death; median progression-free survival (PFS) and overall survival (OS) were 2.5 and 47 months, respectively. Considering patients' MRD status in BM as the reference, PRD detection using NGF showed positive and negative predictive values of 100% and 73%, respectively. Presence of PRD helped identifying patients at risk of imminent progression among those with positive MRD in BM. Patients with undetectable PRD according to both NGF and MS showed 2-year PFS and OS rates of 97% and 100%, respectively. In multivariate analyses including the Revised International Staging System and the complete remission status, only MRD in BM and PRD by NGF showed independent prognostic value for PFS. This study supports the use of less invasive PRD monitoring during maintenance or observation in transplant-eligible patients with MM.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
15秒前
44秒前
俭朴的大有完成签到,获得积分10
45秒前
TXZ06完成签到,获得积分10
47秒前
49秒前
1分钟前
执着夏山发布了新的文献求助100
1分钟前
1分钟前
CipherSage应助科研通管家采纳,获得10
1分钟前
Z小姐完成签到 ,获得积分10
1分钟前
梨梨lilili完成签到,获得积分20
2分钟前
JamesPei应助cacaldon采纳,获得10
2分钟前
研友_VZG7GZ应助梨梨lilili采纳,获得30
2分钟前
cacaldon完成签到,获得积分10
2分钟前
h0jian09完成签到,获得积分10
2分钟前
筱灬发布了新的文献求助20
2分钟前
2分钟前
2分钟前
梨梨lilili发布了新的文献求助30
3分钟前
科研通AI2S应助serena0_0采纳,获得10
3分钟前
3分钟前
ccc完成签到 ,获得积分10
3分钟前
斯文败类应助梨梨lilili采纳,获得10
3分钟前
4分钟前
4分钟前
执着夏山发布了新的文献求助10
4分钟前
5分钟前
uikymh完成签到 ,获得积分0
5分钟前
5分钟前
李伟发布了新的文献求助10
5分钟前
5分钟前
皎皎完成签到,获得积分10
5分钟前
乐乐应助科研通管家采纳,获得10
5分钟前
cjx完成签到,获得积分10
6分钟前
6分钟前
6分钟前
henrychyeung发布了新的文献求助10
7分钟前
皎皎发布了新的文献求助10
7分钟前
7分钟前
7分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146739
求助须知:如何正确求助?哪些是违规求助? 2798045
关于积分的说明 7826588
捐赠科研通 2454566
什么是DOI,文献DOI怎么找? 1306391
科研通“疑难数据库(出版商)”最低求助积分说明 627708
版权声明 601527